register

News & Trends - MedTech & Diagnostics

New hospital-private health insurer partnership to limit out of pocket costs for patients

Health Industry Hub | May 5, 2023 |

MedTech & Diagnostics News: As cost-of-living pressures continue to impact families across Australia, a new two-year deal aims to help limit out of pocket costs for patients and support local regional communities.

St John of God Health Care Group CEO, Bryan Pyne, said the agreement with Bupa was a win for local communities and continued to provide access and choice to healthcare.

“As a not-for-profit hospital provider, we seek partnerships that help us ensure all the communities we serve have access to high quality, compassionate and patient centred private health care,” Mr Pyne said.

“Our partnership with Bupa helps provide our patients access to local doctors and surgeons at their choice of hospital. In areas like Geelong, where we have provided a maternity service for many years and is now experiencing a baby boom, we think it’s important that parents continue to have options to have their babies in a private hospital closer to home, which can reduce travel time and helps reduce some of the stress that comes with parenthood.”

This news follows the recent announcement of a joint venture between the nation’s second-largest private hospitals operator, Healthscope, and health insurer nib and US health giant Cigna, Honeysuckle Health – a first-of-its-kind five-year strategic partnership.

Bupa Health Insurance Managing Director, Chris Carroll, said the partnership with St John of God Health Care showcased how insurers and hospitals could work together to keep private health care affordable with a patient-first mindset.

He said the partnership supported Bupa to have one of the largest hospital networks of any major health fund in Australia.

“Our partnership with St John of God Health Care aims to provide our regional members with peace of mind that they can receive high value care close to their home and in their communities,” said Chris Carroll, Bupa Health Insurance Managing Director.

“We know how loyal regional and suburban communities are to their local hospitals, and we’re thrilled this partnership helps limit out of pocket costs for our members at a leading health care provider.

“Partnerships with our private hospitals helps reduce out of pocket costs, support our world-leading mixed health system and helps take pressure off our public hospitals and their waiting lists.”

Bupa’s renewed partnership with St John of God Health Care is the latest of many including Ramsay Health Care, Cabrini Health, Epworth HealthCare and Mater Health.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms

Health Industry Hub | April 17, 2025 |

Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]

More


News & Trends - Pharmaceuticals

Oncologists pioneer liquid biopsy-guided treatment in lung cancer

Oncologists pioneer liquid biopsy-guided treatment in lung cancer

Health Industry Hub | April 17, 2025 |

Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]

More


Medical and Science

The high cost of record low research funding

The high cost of record low research funding

Health Industry Hub | April 17, 2025 |

Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]

More


News & Trends - Pharmaceuticals

UCB secures dermatology indication with first dual IL-17A/F inhibitor

UCB secures dermatology indication with first dual IL-17A/F inhibitor

Health Industry Hub | April 17, 2025 |

UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]

More


This content is copyright protected. Please subscribe to gain access.